Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
Crown Laboratories’ Acquisition of StriVectin
GPI Capital’s $175 Million Growth Equity Investment in Hopper
Kirkland & Ellis and McCarthy Tétrault represented GPI Capital in connection with the investment in Hopper, assisted by Osler, Hoskin & Harcourt LLP. GPI Capital executed...
Saudi Aramco’s US$6 Billion Sukuk Offering
White & Case LLP has advised Saudi Arabian Oil Company, while Latham & Watkins and the Law Office of Salman M. Al-Sudairi have advised the Dealers...
Aceto’s Acquisition of A&C
On April 15, 2021, Aceto, a global provider of specialty materials in the life sciences and advanced technology markets, announced its acquisition of A&C, a GMP...
Abu Dhabi Ports’ EMTN Programme and $1 Billion Notes Offering
Latham & Watkins advised the arrangers and dealers in relation to the establishment of a Euro Medium Term Note Programme by Abu Dhabi Ports Company PJSC...
Acasti Pharma Inc.’s Acquisition of Grace Therapeutics
Osler, Hoskin & Harcourt LLP advised Acasti Pharma on the deal, while Reed Smith advised Grace Therapeutics. Acasti Pharma entered into of a definitive agreement to acquire Grace...